Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease

Recessively inherited loss-of-function mutations in the PTEN-induced putative kinase 1(Pink1), DJ-1 (Park7) and Parkin (Park2) genes are linked to familial cases of early-onset Parkinson's disease (PD). As part of its strategy to provide more tools for the research community, The Michael J. Fox Foundation for Parkinson's Research (MJFF) funded the generation of novel rat models with targeted disruption ofPink1, DJ-1 or Parkin genes and determined if the loss of these proteins would result in a progressive PD-like phenotype. Pathological, neurochemical and behavioral outcome measures were collected at 4, 6 and 8months of age in homozygous KO rats and compared to wild-type (WT) rats. Both Pink1 and DJ-1 KO rats showed progressive nigral neurodegeneration with about 50% dopaminergic cell loss observed at 8 months of age. ThePink1 KO and DJ-1 KO rats also showed a two to three fold increase in striatal dopamine and serotonin content at 8 months of age. Both Pink1 KO and DJ-1 KO rats exhibited significant motor deficits starting at 4months of age. However, Parkin KO rats displayed normal behaviors with no neurochemical or pathological changes. These results demonstrate that inactivation of the Pink1 or DJ-1 genes in the rat produces progressive neurodegeneration and early behavioral deficits, suggesting that these recessive genes may be essential for the survival of dopaminergic neurons in the substantia nigra (SN). These MJFF-generated novel rat models will assist the research community to elucidate the mechanisms by which these recessive genes produce PD pathology and potentially aid in therapeutic development.

[1]  O. Hornykiewicz.  Chemical neuroanatomy of the basal ganglia — normal and in Parkinson's disease , 2001, Journal of Chemical Neuroanatomy.

[2]  Michael R. Duchen,et al.  PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death , 2009, Molecular cell.

[3]  M. Farrer.  Genetics of Parkinson disease: paradigm shifts and future prospects , 2006, Nature Reviews Genetics.

[4]  M. Quik,et al.  Pre‐synaptic dopaminergic compensation after moderate nigrostriatal damage in non‐human primates , 2008, Journal of neurochemistry.

[5]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[6]  P. Pástor,et al.  PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010, Brain : a journal of neurology.

[7]  I. Martin,et al.  Recent advances in the genetics of Parkinson's disease. , 2011, Annual review of genomics and human genetics.

[8]  A. Panov,et al.  Species- and tissue-specific relationships between mitochondrial permeability transition and generation of ROS in brain and liver mitochondria of rats and mice. , 2007, American journal of physiology. Cell physiology.

[9]  Bryan L Roth,et al.  Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* , 2003, Journal of Biological Chemistry.

[10]  G. Snyder,et al.  Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. , 1990, The Journal of pharmacology and experimental therapeutics.

[11]  E. Bézard,et al.  Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  I. Whishaw,et al.  Variation in visual acuity within pigmented, and between pigmented and albino rat strains , 2002, Behavioural Brain Research.

[13]  P. Verstreken,et al.  Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function , 2009, EMBO molecular medicine.

[14]  D. Putt,et al.  Renal and hepatic toxicity of trichloroethylene and its glutathione-derived metabolites in rats and mice: sex-, species-, and tissue-dependent differences. , 2001, The Journal of pharmacology and experimental therapeutics.

[15]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[16]  David W. Miller,et al.  Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) protein , 2005, Neuroscience Letters.

[17]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[18]  A. Singleton,et al.  The genetics and neuropathology of Parkinson’s disease , 2012, Acta Neuropathologica.

[19]  D. Hernandez,et al.  Lewy bodies and parkinsonism in families with parkin mutations , 2001, Annals of neurology.

[20]  Y. Wang,et al.  Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT1A receptor stimulation in the rat , 2009, Neuroscience.

[21]  J. Eberling,et al.  PET studies of functional compensation in a primate model of Parkinson's disease , 1997, Neuroreport.

[22]  Ignacio Anegon,et al.  Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases , 2009, Science.

[23]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[24]  Y. Shimo,et al.  Lewy body pathology in a patient with a homozygous Parkin deletion , 2013, Movement disorders : official journal of the Movement Disorder Society.

[25]  T. Dawson,et al.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  I. Liste,et al.  Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats. , 1997, Neuroreport.

[27]  C. Gerfen,et al.  Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter , 2007, Neurobiology of Disease.

[28]  R. Hilker,et al.  Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers , 2005, Annals of neurology.

[29]  由希子 宇佐見.  DJ-1 associates with synaptic membranes , 2011 .

[30]  Mark R. Cookson.  DJ‐1, PINK1, and their effects on mitochondrial pathways , 2010, Movement disorders : official journal of the Movement Disorder Society.

[31]  Wolfdieter Springer,et al.  Regulation of PINK1-Parkin-mediated mitophagy , 2011, Autophagy.

[32]  Sahar Ahmad,et al.  A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: A stereological study , 2012, Journal of Neuroscience Methods.

[33]  Tiffany Mathews,et al.  Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice* , 2005, Journal of Biological Chemistry.

[34]  Simon C Watkins,et al.  Automated imaging system for fast quantitation of neurons, cell morphology and neurite morphometry in vivo and in vitro , 2013, Neurobiology of Disease.

[35]  Aj Lees,et al.  Parkinson's disease (vol 373, pg 2055, 2009) , 2009 .

[36]  V. Baekelandt,et al.  Distribution of PINK1 and LRRK2 in rat and mouse brain , 2006, Journal of neurochemistry.

[37]  P. Calabresi,et al.  Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 , 2005, Neuron.

[38]  Kindiya D. Geghman,et al.  Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment , 2013, Experimental Neurology.

[39]  Marco A. S. Baptista,et al.  A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson’s Research , 2013, Disease Models & Mechanisms.

[40]  J. Trempe,et al.  Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection , 2013, Front. Neurol..

[41]  Douglas R. Porter,et al.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice , 2007, Proceedings of the National Academy of Sciences.

[42]  A. Bentivoglio,et al.  PINK1 mutations are associated with sporadic early‐onset parkinsonism , 2004, Annals of neurology.

[43]  David S. Park,et al.  Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease , 2012, Proceedings of the National Academy of Sciences.

[44]  B. Levant,et al.  Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats , 2013, Neuroscience Letters.

[45]  L. Liaw,et al.  Targeted Genome Modification in Mice Using Zinc-Finger Nucleases , 2010, Genetics.

[46]  A. Mitsumoto,et al.  DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin , 2001, Free radical research.

[47]  M. Iwata,et al.  Parkin-positive autosomal recessive juvenile parkinsonism with α-synuclein-positive inclusions , 2004, Neurology.

[48]  M. Augustin,et al.  Parkin expression in the adult mouse brain , 2000, The European journal of neuroscience.

[49]  Yoshio Kato,et al.  targeted gene knockout by direct delivery of zinc-finger nuclease proteins , 2012 .

[50]  David S. Park,et al.  Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. , 2010, Human molecular genetics.

[51]  D. C. Sterio.  The unbiased estimation of number and sizes of arbitrary particles using the disector , 1984, Journal of microscopy.

[52]  P. Garris,et al.  Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism , 2001, Journal of Neuroscience Methods.

[53]  R. Mach,et al.  Regulation of dopamine presynaptic markers and receptors in the striatum of DJ-1 and Pink1 knockout rats , 2013, Neuroscience Letters.

[54]  M. Goldberg,et al.  Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease , 2014, Neurobiology of Disease.

[55]  Jie Shen,et al.  Absence of nigral degeneration in aged parkin/DJ‐1/PINK1 triple knockout mice , 2009, Journal of neurochemistry.

[56]  M. Zigmond,et al.  Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. , 1984, Archives of neurology.

[57]  O. Levy,et al.  The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[58]  H. Cai,et al.  Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function , 2008, Neurobiology of Disease.